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Wounds are the result of injuries to the skin that disrupt the other soft tissue. Healing of a wound is a complex and protracted
process of tissue repair and remodeling in response to injury. Various plant products have been used in treatment of wounds
over the years. Wound healing herbal extracts promote blood clotting, ﬁght infection, and accelerate the healing of wounds.
Phytoconstituents derived from plants need to be identiﬁed and screened for antimicrobial activity for management of wounds.
The in vitro assays are useful, quick, and relatively inexpensive. Small animals provide a multitude of model choices for various
human wound conditions. The study must be conducted after obtaining approval of the Ethics Committee and according
to the guidelines for care and use of animals. The prepared formulations of herbal extract can be evaluated by various
physicopharmaceutical parameters. The wound healing eﬃcacies of various herbal extracts have been evaluated in excision,
incision, dead space, and burn wound models. In vitro and in vivo assays are stepping stones to well-controlled clinical trials
of herbal extracts.
1.Introduction
Optimum healing of a cutaneous wound requires a well-
orchestrated integration of the complex biological and
molecular events of cell migration and proliferation and of
extracellular matrix deposition and remodeling. Wound care
and maintenance involves a number of measures including
dressing and administration of painkillers, use of anti-
inﬂammatory agents, topical systemic antimicrobial agents,
and healing promoting drugs. Burn wound care is needed
according to the severity of burn. The aim of wound care
is to promote wound healing in the shortest time possible
with minimal pain, discomfort, and scarring to the patient
and must occur in a physiological environment, conducive
to tissue repair and regeneration. This systematic review of
in vitro and in vivo experiments could promote closer col-
laboration between the research communities and encourage
an iterative approach to improving the relevance of various
models to clinical trial design.
2.Wound
Wound is deﬁned as disruption of cellular, anatomical, and
functional continuity of a living tissue. It may be produced
by physical, chemical, thermal, microbial, or immunological
insult to the tissue. When skin is torn, cut, or punctured it
is termed as an open wound and when blunt force trauma
causes a contusion, it is called closed wound, whereas the
burn wounds are caused by ﬁre, heat, radiation, chemicals,
electricity, or sunlight [1, 2].
3.WoundHealing
Wound healing is the interaction of a complex cascade of
cellular and biochemical actions leading to the restoration
of structural and functional integrity with regain of strength
of injured tissues. It involves continuous cell-cell interaction
andcell-matrixinteractionsthatallowtheprocesstoproceed
in diﬀerent overlapping phases and processes including
inﬂammation, wound contraction, reepithelialization, tissue
remodelling,andformationofgranulationtissuewithangio-
genesis. The phases of wound healing normally progress in
a predictable, timely manner, and if they do not, healing may
progress inappropriately to either a chronic wound such as
a venous ulcer or pathological scarring such as a keloid scar
[3].2 Evidence-Based Complementary and Alternative Medicine
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Figure 1: Schematic illustration of practices in wound healing studies of plants.
4. Role of Plants
Plants have the immense potential for the management and
treatment of wounds. A large number of plants are used by
tribal and folklore in many countries for the treatment of
wounds and burns. These natural agents induce healing and
regenerationofthelosttissuebymultiplemechanisms.These
phytomedicinearenotonlycheapandaﬀordablebutarealso
safe. The presence of various life-sustaining constituents in
plants has urged scientist to examine these plants with a view
to determine potential wound healing properties [4]. Many
phytopharmaceutical laboratories are now concentrating
their eﬀorts to identify the active constituents and modes of
actionofvariousmedicinalplants[5].Themedicinalvalueof
these plants lies in bioactive phytochemical constituents that
produce deﬁnite physiological action on the human body
[6]. These constituents include various chemical families
like alkaloids, essential oils, ﬂavonoids, tannins, terpenoids,
saponins, and phenolic compounds [7].
The screening of herbal extracts has been of great interest
to the scientists for the discovery of new eﬀective drugs
[8]. A number of reports concerning the antibacterial, anti-
inﬂammatory, and wound healing activity of various plants
have appeared in the literature, but the vast majority has yet
tobeexplored. Variouspharmacologicalreportsareavailable
on plants employing diﬀerent wound healing models and its
underlying molecular mechanism for the validation of their
traditional claims and development of safe and eﬀective and
globally accepted herbal drugs for wounds. The schematic
illustration of practices in wound healing studies of plants
is shown in Figure 1.Evidence-Based Complementary and Alternative Medicine 3
5. PhytoconstituentExtraction
It involves the separation of the medicinally active portion
from plant using selective solvents. Standard techniques
separate out soluble metabolites leaving behind insoluble
cellular marc. The products so obtained are relatively
complex mixtures of a number of groups of metabolites
either in liquid form or semisolid state or after removing
the solvent resulting in dried powdered extracts intended
for oral or topical use. These include classes of preparations
known as decoctions, infusions, ﬂuidextracts, tinctures,
pilularextracts,orpowderedextracts.Theherbalextractthus
obtainedmaybereadyforuseasamedicinalagentassuch,or
it may be further processed to be incorporated in any dosage
form. An extract may be further processed through various
techniques of fractionation to isolate individual chemical
entities to be used as modern drugs [9]. There are many
processes patented throughout the world for extraction of
plant ingredients. Percentage utilization of diﬀerent methods
of phytoconstituent extraction is presented in Figure 2.T h e
datawascalculatedfromthepublishedoriginalresearcharti-
cles compiled from various sources during the composition
ofthispaper.Thegeneraltechniquesemployedforextraction
of phytoconstituents are as follows.
5.1. Decoction. In this process, the plant material is boiled
i nas p e c i ﬁ e dv o l u m eo fw a t e rf o rad e ﬁ n e dt i m e ;i ti st h e n
cooled and strained or ﬁltered. This procedure is suitable
for extracting water-soluble, heat-stable constituents. The
starting ratio of plant material to water is ﬁxed, ranging from
1:4 or 1:20. The volume is then brought down to one-
fourth its original volume by boiling during the extraction
procedure. Then, the concentrated herbal extract is ﬁltered
and used as such or processed further [10].
5.2. Infusion. It is prepared by leaving the plant material
soaked in the solvent (generally at room temperature) for
a period of time, with or without intermittent shaking,
followed by ﬁltration to separate away the plant debris. If the
plant material has settled, then the upper solvent extract can
be decanted oﬀ and replaced if necessary with fresh solvent.
These are dilute solutions of the readily soluble constituents
of plant material [11].
5.3. Maceration. It is a process of preparation of a herbal
extract by soaking plant material in water, vegetable oil, or
some organic solvent. The whole or coarsely powdered, air-
dried, and pulverised plant material is placed in a stoppered
container with the solvent and allowed to stand at room
temperature for a period of at least 3 days with frequent
agitation until the soluble matter has dissolved. The mixture
then is strained, the marc (the damp solid material) is
pressed, and the combined liquids are clariﬁed by ﬁltration
or decantation after standing [12].
5.4. Percolation. The plant material is packed into the
columnwithatapatthelowerend,andanintermediaryﬁlter
or sinter is provided to prevent escape of the solid material.
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Figure 2: Percentage utilization of diﬀerent methods of phytocon-
stituent extraction, calculated from the published research articles.
The tap is opened and the extraction solvent (at room
temperature or above) is poured in at the top and allowed to
trickle through the material. Chemicals which are extracted
are collected in a suitable container. The evaporation results
in the dry herbal extract. The process can be repeated as
many times as necessary to ensure full extraction [13].
5.5. Solvent Extraction. When the plant material comes
in contact with a solvent, the soluble components in the
material move to the solvent which results in the mass
transfer of soluble active ingredient to the solvent, and this
takes place in a concentration gradient. The rate of mass
transfer decreases as the concentration of active ingredient
in the solvent increases, until equilibrium is reached; that is,
the concentrations of active ingredient in the plant material
and the solvent are the same. Since mass transfer of the
active ingredient also depends on its solubility in the solvent,
heatingthesolventcanenhancesthemasstransfer.Moreover,
if the solvent in equilibrium with the plant material is
replaced with fresh solvent, the concentration gradient is
changed [14].
5.6. Steam Distillation. This is carried out for the extraction
of essential oils by mixing the plant material with water and
heated to boiling. The emergent vapours are collected and
allowed to condense, and the oil separates from the water.
However, if prolonged boiling is to be avoided, then the
steamfromaseparategeneratorcanbepassedeitherthrough
plant material suspended in water but not boiled (hydro
steam distillation) or directly through the plant material laid
out on a mesh arrangement between the steam inlet and the
condenser (direct steam distillation). Once the oil and steam
have condensed, the two layers may be separated by physical
means using separating funnel [15].
5.7. Soxhlet Extraction. The plant material is placed inside a
thimble made from thick ﬁlter paper, which is loaded into4 Evidence-Based Complementary and Alternative Medicine
the main chamber of the Soxhlet extractor. This extractor
is placed onto a distillation ﬂask containing the solvent.
The Soxhlet is then equipped with a condenser, and the
solvent is heated to reﬂux. The warm solvent vapour travels
up a distillation arm and ﬂoods into the chamber housing
the thimble. When the chamber is almost full, it gets
automaticallyemptiedbyasiphonsidearmbackdowntothe
distillation ﬂask. This cycle may be allowed to repeat many
times so that the desired compound gets concentrated in the
distillation ﬂask [2, 16].
The solvent extracts are ﬁltered, concentrated under
reduced pressure (30±10mbar) in a rotary evaporator at
30◦C–60◦C to a syrupy consistency and ﬁnally dried in
vacuum desiccator using sodium sulphide [2]. Whereas the
aqueous extracts are collected and ﬁltered, the concentrated
materialisreducedtoamassatroomtemperature,andwater
is removed by placing it in desiccators and then submitted to
lyophilization by a freeze-dryer, to produce powdered form
oftheextract.Lyophilizationremovesthewaterandstabilises
the extract so that it can retain satisfactory pharmacological
activity during long term storage [17]. The weight of the
dried mass is recorded and used for experimental studies.
6.PhytoconstituentAnalysis
The presence of alkaloids is detected by Dragenddorﬀ’s
reagent, Mayer’s reagent, Hager’s reagent, and Wagner’s
reagent whereas steroids and triterpenes by Salkowski’s
and Liberman Burchardt’s tests and glycosides by Legal’s
test, Borntrager’s test while carbohydrates by Molisch’s test,
Fehling’s test, Barfoed’s test, and Benedict’s test. Proteins
and amino acids are distinguished by Millon’s reagent and
Biuret’s test. Flavonoids are identiﬁed by alkaline reagent
test, lead acetate test, Shinoda test, and zinc hydrochloric
acid reduction test and saponins by froth test and foam
test. Phenolic compounds and tannins are spotted by ferric
chloride test and lead acetate test whereas tannins by the
gelatin test [18, 19].
7. AntimicrobialActivity
For the disc diﬀusion assay, 5mm discs of Whatman ﬁlter
paper (no. 1) is immersed in the slurry of herbal extract
(mg/mL) made in sterile water. The discs are then placed
onto the surface of nutrient agar plates inoculated with 24h
old culture of the appropriate bacteria and scored for the
presence of a zone of clearing around the disc after 48h
of incubation at 37◦C. Control disks contained solvents,
w h e r e a sc o m m e r c i a ld r u g sa r eu s e da ss t a n d a r d s[ 11].
By agar well diﬀusion method, sterilized Muller Hinton
agar plates are seeded with 1 × 106 cfu/mL concentration of
testorganisms.Using asterilecorkborer(6-7mmdiameter),
wells are bored on the surface of agar and the solution
of herbal extract (mg/mL) in dimethylsulfoxide (DMSO) is
introduced into appropriate well. Blank DMSO in separate
well serves as control. The plates are kept undisturbed at
room temperature for prediﬀusion period of 30min and
incubated for 24h at 37◦C. After incubation, the diameter of
the inhibition zone for each well is measured and the mean
obtained [20].
The minimum inhibitory concentration (MIC) is deter-
mined using the agar dilution technique. Serial concentra-
tions of the herbal extract (mg/mL) are incorporated into
nutrient agar plates. Thereafter, 24h actively growing culture
of the test organism is then streaked on the plate. MIC for
each organism is taken as the lowest concentration of the
herbal extract in the nutrient agar that inhibited the visible
growth of the organism after 24h of incubation at 37◦C[ 21].
8.In vitro Studies
Tissue repair concerns many events, both contractile and
chemical, and the causing of a wound on any body surface
stimulates the wound healing in the skin, which is a
complex process characterized by angiogenesis reepithelial-
ization, granulation tissue formation, and remodeling of
extracellular matrix. These steps, accomplished primarily by
dermalﬁbroblastsandkeratinocytes,arewellorchestratedby
bioactive molecules including growth factors, cytokines and
theirreceptors,andmatrixmolecules.Themaincellarchitect
participating in this process of healing by contraction is
the ﬁbroblast, which is also involved in the synthesis and
deposition of the extracellular matrix. Hence, the ﬁbroblast
in vitro model is integral to correlating the contractile events
of wound healing [22]. Therefore, the human dermal ﬁbrob-
last (HDFs) growth-stimulating activity of plant compounds
is an appropriate technique by which to determine the
wound healing properties of the test compounds [23]. Key
to wound healing processes are the proliferation, migration,
and functioning of ﬁbroblasts and keratinocytes, thus they
are the basis of in vitro studies. Percentage utilization of
diﬀerent techniques for in vitro studies is presented in
Figure 3. These in vitro assays can be useful, since they are
quick, relatively inexpensive, and can be used to screen a
wide variety of conditions or samples simultaneously but are
incapable of replicating all the factors involved in complex
processes of wound healing.
8.1. Chick Chorioallantoic Membrane (CAM) Assay. The
CAMmodelisusedtoassesstheangiogenicactivityofherbal
extract. Nine-day-old fertilized chick eggs are selected, and a
small window of 1.0cm2 is made in the shell. The window
is opened, and a sterile disc of methylcellulose loaded with
herbal extract is placed at the junction of two large vessels
on CAM. The window is resealed by tape, and the eggs are
incubated at 37◦C in a well-humidiﬁed chamber for 72h.
Then, eggs are opened, and new blood vessel formation
is observed in CAM treated by herbal extract which are
compared with CAM containing disc without herbal extract
(control) and the CAM treated with 10μL 1000AU/mL
bFGF (Fibroblast Growth Factor) as a standard [24]. The
photographic images of the CAM model are analyzed for
quantitative morphometric analysis of the density of blood
capillaries in terms of the number of red pixel per unit areas
using ImageJ software and AngioQuant software [25, 26].Evidence-Based Complementary and Alternative Medicine 5
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Figure 3: Percentage utilization of diﬀerent techniques for in vitro
studies, calculated from the published research articles.
8.2. Fibroblast Bioassay. Human dermal ﬁbroblast (HDF)
cells from postauricular surgery are grown to conﬂuence
after which they are removed from the culture ﬂask using
trypsin/EDTA after washing with phosphate buﬀer saline
(PBS). HDFs are resuspended in 50mL of Dulbeccos’
modiﬁed eagle medium (DMEM), centrifuged at 2600rpm
for 5min, and seeded in a 96-well sterile microtitre plate at a
density of 11×103cells/well in DMEM containing 10% fetal
calf serum (FCS), 0.02% fungizone, 1% penicillin, and 2%
streptomycin. After 24h, the media is removed by aspiration.
Solutions are initially solubilized in water and diluted in
DMEM containing 0.5% fetal bovine serum (FBS) (0.5%
FBS is the maintenance level required for HDF growth) to
give a ﬁnal concentration of 100μg/μL. Solutions are ﬁltered
through a 0.2μM sterile ﬁlter prior to addition to the cells,
and 1:1 serial dilutions are prepared. Aliquot (200μL) of
herbal extract, in triplicate, is added to each well. The plates
are left to incubate for 3d. The neutral red assay is used
to analyze the eﬀects of the herbal extract on the growth
of ﬁbroblasts. Neutral red dye (1.2mL) is added to 78.8mL
of Hanks’ balanced salt solution (HBSS). This is incubated
for 10min at 37◦C after which it is centrifuged at 2600rpm
f o r5 m i na n d1 0 0 m La d d e dt oe a c hw e l l .T h ep l a t e sa r e
incubated for 2.5h, the media is tipped oﬀ, and the cells were
washed with 100μL of 1% formic acid followed by 100μLo f
1% acetic acid. The absorbance is recorded at 550nm, and
the values obtained for the solutions are compared with the
control (0.5% FCS) [23].
The ﬁbroblasts can also be cultured in a laboratory
from fetal rat skin and subcultured through three passages
before use. Cells are incubated in an atmosphere of 5%
CO2, 95% air at 37◦C in a tissue culture incubator, and
suspended at 0.5×105 viable cells/5mL in the growth media
(DMEM). The viability of the cells is assessed by trypan
blue exclusion. The suspended cells are fortiﬁed with 10%
FCS and allowed to equilibrate for 3d. Herbal extract and
standard commercial drug as control is introduced into
the medium separately on day 3 at a dose of 40mL in a
concentration of 1mg/mL, in phosphate buﬀered saline pH
7.4. The medium is changed periodically. On day 9, the
medium is aspirated, and cells are washed with phosphate
buﬀered saline. Half the quantity of cells is assayed for
hydroxyproline content and the other half for DNA. Values
are expressed as mg hydroxyproline/100mg DNA [22].
8.3. Keratinocytes Assay. Keratinocytes can be isolated from
the residual skin samples removed during surgery or human
foreskins that can be obtained from circumcised newborn
babies. The residual skin graft is treated overnight with 0.3%
solution of trypsin at 4◦C, whereas foreskins are washed
extensively with multiple changes of PBS, subcutaneous
tissue is removed, and the remaining samples are enzy-
matically dissociated in multiple changes of 0.25% trypsin
and versene (50:50). Epidermal sheets are peeled from
the dermis, minced, and dispersed in trypsin solution by
repeatedpipetting.Thecellsuspensionsarepelletedfromthe
trypsin solution, sequentially suspended, and washed with
PBS by centrifugation at 1000×gf o r5m i na t2 0 ◦C. Prior
to cocultivation with keratinocyte, proliferation activity of
ﬁbroblasts is stopped using a solution of Mitomycin C at a
concentration of 25μg/mL for 3h. These cells are raised in a
tissue culture dish with feeder cells (J2 mouse ﬁbroblasts).
Feeder cells are seeded on a cover glass at a density of
25,000cells/cm2 and cultured for 24h. A suspension of
keratinocytes (20,000cells/cm2) is then added, and cells
are cultivated in a keratinocyte serum-free growth medium
(KGM) at 37◦C and 3.3% CO2. Cultures are maintained in
a growth medium consisting of DMEM and Ham’s nutrient
mixture F12 at a 3:1 ratio. Cultures are fed every 3 days
and subcultured by dispersal in 0.025% trypsin in PBS and
replated at a split ratio of 1:3. Cultures are used between
passages 2 and 3 [27, 28].
For in vitro assay human keratinocytes, either second
or third passage (P2 or P3) is trypsinized, seeded into
32mm, tissue culture dishes at densities from 5 × 105 to
8 × 105 cells/dish in KGM, and fed every 2d until they
reached 100% conﬂuence. The medium is then replaced with
RPMI 1640/10% FCS. After 4h a scratch is made with a
micropipette tip, and cells are washed with PBS in order to
remove loosened debris. RPMI 1640/2% FCS medium with
or without the herbal extract (1mg/mL to 300mg/mL) is
added to sets of 2 dishes per dose. Each dish is orientated
on the bottom of a six-well plate lid and ﬁxed using glue.
For each scratch, four consecutive ﬁelds are selected using
the following criteria: relatively little cell debris within the
scratch, even scratch, with straight edges, both edges visible
under a single ﬁeld using the X 10 objective, ﬁelds not
too close to either end of the scratch, where distortions
uncharacteristic of the main part of the scratch could be seen
tooccurduringthe“healing”process.Thecoordinatesonthe
vernier scales of the inverted microscope stage are noted for
every ﬁeld. The condition of each ﬁeld is recorded on video
at various intervals over periods up to 72h, as long as there
was still a denuded area. Photographs of each ﬁeld are also
taken at the same time points. The average percentage of the6 Evidence-Based Complementary and Alternative Medicine
initial area still denuded is calculated for each treatment set
for the total of 8 ﬁelds per set [29].
To study the eﬀect of plant extract on keratinocyte
migration, the normal human keratinocytes are cultured
to conﬂuence in a six-well culture plate, and the culture
medium is drained away. A wound (width 0.5mm) is created
on an area of cells by gentle scraping with a rubber stick and
moving back and forth against the top of the culture. The
wells are washed four times with PBS to remove remaining
cellular debris. Cultures are maintained with a medium
supplemented with 5% (FBS). The herbal extract is added
to the culture at 100mg/mL, and the control culture received
only PBS. Wound restoration is photographed at 16, 25, and
40h after injury. And to study the eﬀect of herbal extract
on epidermis formation, the keratinocytes are raft cultured,
and when the cells reached 90% of conﬂuency, they are
trypsinized on a collagen matrix for raft culture as follows.
Mouse ﬁbroblasts are mixed with type I collagen matrix at a
density of 17,000 cells per Millericell and seeded in 12mm
Millericell. Keratinocytes are then seeded on the matrix at
17,000 cells per Millericell. Cells are cultured submerged
in media for 7d, transferred to the air-liquid interface and
then raised for 21d. The herbal extract is applied to cells
with serum-free media at 0, 0.05, 0.5, and 50mg/mL every
2d. Part of the epidermal tissue formed by 3 weeks of
culture is taken, ﬁxed in Carnoy solution (ethanol-glacial
acetic acid-chloroform in 6:1:3 ratio by volume), washed
with 60% then 80% ethanol, and put in paraﬃnb l o c k sf o r
morphological comparison [27].
9. Effect of In vitro Studies
The herbal extracts containing compounds with angiogene-
sis modulating properties showed strong angiogenic activity
in CAM treated with herbal extract, by increasing the size
and number of blood vessels as compared to control (sterile
disc without herbal extract or normal saline solution). For
example, the herbal extracts of Aloe vera [26], Alternanthera
brasiliana [25], Dalbergia odorifera, Epimedium sagittatum,
and Trichosanthes kirilowii [24] were screened using CAM
assay for the analysis of their wound healing potential. The
changes in the distribution and density of CAM vessels next
to the implant are evaluated by means of a stereomicroscope
at regular intervals following the graft procedure, and the
percentage increase of blood vessels could be calculated by
the following formula:

Vessel number of CAM treated by herbal extract −Vessel number of CAM treated by normal saline


Vessel number of CAM treated by normal saline

× 100
= Percentage increase of blood vessels.
(1)
The herbal extract promotes ﬁbroblast proliferation and
motility; this activity was also greater than that of a positive
control in which ﬁbroblasts were allowed to grow in 10%
FCS. The use of 10% FCS to indicate HDF growth stimu-
lation is an established comparative technique and provides
a suitable positive control. The herbal extracts of Celosia
argentea [30], Buddleja globosa [31], Onosma argentatum
[32], and Scrophularia nodosa [23] were analysed using
ﬁbroblasts bioassay for the determination of their wound
healing potential. The activity of herbal extract neither
alters motility and proliferation of primary keratinocytes
nor show any increase or decrease in EGFR (epidermal
growth factor receptor) phosphorylation. It only stimulated
the downstream eﬀector in ERK (extracellular signal regu-
lated kinase) activation when compared with control. For
example, the herbal extracts of Chromolaena odorata [29],
Combretum smeathmanni, Phyllanthus muellerianus,a n d
Pycnanthus angolensis [33] were analysed using keratinocytes
assay for the determination of their wound healing potential.
10.In vivo Studies
The small mammals have emerged as the model of choice for
such studies, which are beneﬁcial for multiple reasons. They
are inexpensive, easily obtainable, require less space, food,
and water, easy to maintain, and can be genetically modiﬁed
[34]. Additionally, they often have multiple oﬀspring, which
develop quickly allowing experiments to proceed through
multiple generations. Small animals usually have accelerated
modesofhealingincomparisontohumans,thusexperiment
duration lasts for days, in contrast to weeks or months
in human experiments. Some small mammals can easily
be altered genetically and provide a wound model capable
of approximating defective human conditions such as dia-
betes, immunological deﬁciencies, and obesity [35]. Another
advantageof smallmammalmodels is their ability to serve in
experiments where death is an endpoint.
11.AnimalEthicsApproval
Animal Ethics Committee (AEC) is institutionalised in many
countries, which regulates and authorises all use of animals
for research, teaching, or experimentation subjected to their
variable ethical principles and regulatory guidelines. The
acquisition and use of animals for research or teaching
must not commence before all information requested by
the AEC has been supplied and approval has been granted
by the AEC. The written proposals should place before the
AEC for ethics approval providing suﬃcient information to
satisfy the AEC that the proposed use of animals is justiﬁedEvidence-Based Complementary and Alternative Medicine 7
and complies with the principles of replacement, reduction,
and reﬁnement. Adequate care, housing, and handling
are maintained. Proper and adequate postprocedural care,
includingappropriateveterinaryattention,mustbeprovided
for the animals. Animals must be treated humanely and in
accordance with the Act, and regulations and all procedures
are to be carried out in accordance with the Code of Practice
for the Care and Use of Animals for Scientiﬁc Purposes [36].
12.AnimalHandling
Animal of either sex, same age group, and approximately
of similar weight are employed following an acclimatiza-
tion period of 2–14d. They are maintained at a well-
ventilated animal house under standard controlled condi-
t i o n sa tt e m p e r a t u r e2 2±1◦Ct o3 0±1◦C, relative humidity
35±5t o6 5 ±5%, and kept under either 10/14 or 12/12h
light/dark cycles with free access to food and water ad
libitum. The animals are housed individually in clean, ster-
ile polyvinyl/propylene/metal cages containing autoclaved
paddy husk or paper cuttings as bedding. The animals
are fasted/starved for 12–14h before tests to achieve better
drug absorption through the gastrointestinal tract but given
unrestricted access to clean drinking water [25].
13. DrugFormulation
The next step is to prepare herbal extract formulation (HF)
for either oral or topical administration for the treatment of
wound.
13.1. Oral Formulation. Herbal extract formulation for oral
(HFO) administration is prepared by dissolving 2g of gum
acacia in 100mL of normal saline. From this, 10mL of
solution, which contains 200mg of gum acacia, is used for
dissolving 1g of herbal extract. So that each mL of solution
contains 100mg of herbal extract [10]. The dried herbal
extract may be dissolved in drinking water or tween-80
(0.5%–1.5%) [37]. Since an average rat consumes 110mL
of water/kg/day, thus 100–500mg herbal extract can be
dissolved in 100mL of drinking water [38]. In case of
aqueous extract, a 20% suspension of the leaves is prepared
in 1% gum acacia. The water content of the leaf is found
to be about 80%. The aqueous extract is diluted in the
proportion of 5mL of extracts for each 995mL of distilled
water (ﬁnal concentration=100mg/litre). The suspension of
herbal extract (5%) can be prepared in gum tragacanth (1%-
2%w/v) or in acacia (5%) as suspending/emulsifying agent
using distilled water [39]. Aloe vera extracts in the form
of suspension (5% acacia) is used as standard. The herbal
extract formulations are prepared every fourth day.
13.2. Topical Formulation. Herbal extract formulation for
topical (HFT) administration is prepared in the form of
cream, gel, or ointment according to the choice of appli-
cation. For the preparation of cream the emulsion of oil
and water are added in approximately equal proportions.
Oil phase ingredients and water phase ingredients are heated
separately in double boiling method at 75◦C. At the same
temperature, the water phase ingredients are added into oil
phase while stirring. Finally, a milky solution is formed. The
herbal extract and preservative are added after temperature
is reduced to 35◦C[ 40].
The gel is formulated by wetting polymer using deionise
water. After the polymer becomes fully wet and the mixture
became soggy, it is homogenized using a homogenizer.
Without using heat, the mixture is added with neutralizer,
triethanolamine, and other ingredients such as glycerine
as humectants, moisturizer, chelating agent, and preserva-
tive. Lastly, herbal extract diluted with propylene glycol is
added [41]. Ointment is a homogeneous, semisolid emol-
lient, formulated using hydrophobic, hydrophilic, or water-
emulsifying base to provide preparation that is immiscible,
miscible, or emulsiﬁable with skin secretions. Ointments
can be derived from hydrocarbon (fatty), absorption, water-
removable, or water-soluble bases. Ointments are prepared
by either incorporating the active ingredient(s) into the
chosen base or by melting the base and active ingredient(s)
together [42].
14.Physicopharmaceutical Evaluation
The HFT is evaluated for various physicochemical param-
eters. Rheological properties like apparent viscosity can
be determined using Brookﬁeld viscometer, readability,
extrudability, and ﬂow index. Stability is determined by
exposing the formulation to various temperatures for a
speciﬁc period and if no change occurs in the properties, it
conﬁrmsthattheformulationisstable.ThepHisdetermined
using a pH meter. External characters such as colour, odour,
smoothness, grittiness, and homogeneity are determined by
visual inspection and tested for appearance with no lumps.
For skin irritation test of each formulation, ﬁve human
volunteers are selected, and 1gm of weighed formulation is
applied on an area of 2 square inch to the back of their hand
and covered with cotton. The volunteers are asked to report
after 24h to observe for any reaction or irritation [40, 42].
15.Acute Toxicityand LethalityTest
An acute toxicity study for the herbal extracts in experimen-
tal animals is conducted by staircase method. The animals
arestarvedovernightfedorallywiththeincreasingdoses(mg
or g/kg body weight) of the herbal extract and continuously
observed for mortality and behavioural responses for 48h
andthereafteronce daily upto 14dafteradministration. The
1/10th of the lethal dose is taken as an eﬀective dose ED50
(therapeutic dose). The acute toxicity and lethality (LD50)
of the extract can also be determined using the method of
Lorke [43]. Animals in groups received one of 10, 100, or
1000mg/kg of herbal extract suspended in 3% v/v Tween-
85 administered intraperitoneally and observed for 24h for
a number of deaths. From the results of the ﬁrst test, 200,
400, 800, and 1600mg/kg doses of the herbal extract are
administered to a fresh batch of animals at one animal per
dose and the number of deaths in 24h is recorded. The LD508 Evidence-Based Complementary and Alternative Medicine
is calculated as the geometric mean of the highest nonlethal
dose (800mg/kg) and the lowest lethal dose (1000mg/kg)
[20]. The up and down method can also be adopted for
acute toxicity studies in which the doses are adjusted by a
constant multiplication factor. The dose for each successive
animal is adjusted depending on the previous outcome. The
therapeutic dose is selected based upon the maximum cutoﬀ
value [25].
16. Wound Creation
All the surgical interventions are carried out under sterile
conditions under general anaesthesia. The predetermined
areaforwoundinﬂictionatthebackoftheanimalisprepared
for surgery by removing hairs with depilatory cream/shaving
machine/razor. The animal is anaesthetized with anaes-
thetic ether/chloroform by open mask method or intraperi-
toneally with anaesthetic drug (35mg pentobarbitone
sodium/25mg thiopentone sodium/10mg ketamine/40mg
thiopental/60mg pentobarbital sodium/0.3mg chloralhy-
drate solution per kg body weight of an animal) and placed
on the operation table in its natural position. The animal
can also be anaesthetized using a combination of anaes-
thesia (90mg ketamine+10mg xylazine/10mg xylazine
HCl+50mg ketamine HCl/50mg ketamine HCl+5mg
diazepam/25mg Ketamine HCl+5mg Diazepam per kg
body weight of an animal). The induction of localized
anesthesia can be done by subcutaneous injection of a
lodocain solution (2mL, 2%) or lignocain HCl (1mL,
2%) at and around the area under investigation to render
area painless. The animals are allowed to recover, housed
individually in their cages, and monitored for respiration,
colour, and temperature. They are maintained under stan-
dard husbandry conditions and on a uniform diet and
managed throughout the experimental period. Animals are
closely observed for any infection; those who show signs of
infection are separated and excluded from the study. They
are periodically weighed before and after the experiments.
16.1. Excision Wound Model. Excision wounds are inﬂicted
on the dorsal thoracic region 1–1.5cm away from the verte-
bral column on either side and 5cm away from the ear. After
wound area preparation with 70% alcohol, using a sterile
round seal of 2.5cm diameter or a surgical blade or 5–8mm
biopsy punch, the circular skin from the predetermined area
on the depilated back of the animal is excised to its full thick-
ness to obtain a wound area of about 200–500mm2 diameter
and 2mm depth. Haemostasis is achieved by blotting the
wound with a cotton swab soaked in normal saline [38, 44].
The respective therapeutic treatment is administered either
orally or topically to the animals of respective groups until
completeepithelializationstartingfromthedayofoperation.
Collagen estimation, percentage wound contraction, and
period of epithelialization parameters are studied.
16.2. Incision Wound Model. After wound area preparation
with 70% alcohol, two longitudinal paravertebral incisions
are made through the skin and cutaneous muscles at a
distanceofabout1.5cmfromthemidlineoneitherdepilated
side of the vertebral column with a sterile sharp surgical
blade. Each incision made is 4–6cm in length, and after
complete haemostasis, the parted skin is stitched with
interrupted sutures, 0.5–1.0cm apart using black braided
silk surgical thread (no. 000) and a curved needle (no. 11).
The continuous threads on both wound edges are tightened
for good closure of the wound. The wounds were left
undressed and mopped with a cotton swab [45, 46]. The
respective therapeutic treatment is administered either orally
or topically to the animals of respective groups until 7th–
9th day starting from the day of operation. The sutures were
removed on 7th day, and the skin breaking strength of the
healed wound is measured on 8th–10th day.
16.3. Dead Space Wound Model. In this model, the physical
and mechanical changes in the granuloma tissue are studied.
The subcutaneous dead space wounds are inﬂicted one on
either side of axilla and groin on the ventral surface of
each animal, by making a pouch through a small nick
in the skin. The cylindrical grass piths (2.5 × 0.3cm) or
sterile cotton pellets (5–10mg each) are introduced into
the pouch. Each animal received 2grass piths/cotton pellets
in diﬀerent locations [14, 38] .T h ed e a ds p a c ew o u n di s
createdbysubcutaneousimplantationofasterilized,shallow,
metallic ring (2.5 × 0.3cm) known as the cylindrical pith
or polypropylene tube (2.5 × 0.5cm) on each side beneath
the dorsal paravertebral lumbar skin surface [47, 48], and
wounds are sutured. The respective therapeutic treatment
is administered either orally or topically to the animals
of respective groups for 10 consecutive days. The physical
changes in the granuloma tissue are studied in this model.
16.4. Burn Wound Model. A special metal plate 2×2cmwith
holder is heated to 60◦C and applied to the dorsal area of
the animals for 30s to induce partial thickness burn wound.
Second-degree burns wound can be made by placing the
90◦C hot plate on the selected dorsal area of the animal for
10s. While for full thickness burn wound, the metal plate is
heatedto100◦Candappliedtothedorsalareafor30s[1,49].
Theanimalcanalsobesubjectedtorectangularburnwounds
(20 × 25mm2) using hot (180◦C) brass brick weighing
300g, which is pressed against the shaved skin for 10s in
the treatment group [50]. A cylindrical metal rod (10mm
diameter) is heated over the open ﬂame for 30s and pressed
to the shaved and disinfected surface for 20s on selected
dorsal area of animal under light anaesthesia [51]. Whereas
a partial thickness burns wounds can also be inﬂicted upon
animals starved overnight and under mild anaesthesia, by
pouring hot molten wax at 80◦C into a metal cylinder with
100–300mm2 circular opening, placed on the back of the
animal. On solidiﬁcation of wax after 8–10min the metal
cylinder with wax adhered to the skin is removed, which
left distinctly marked circular burn wound [52]. Animals are
placed in individual cages after recovery from anaesthesia.
The respective therapeutic treatment is administered either
orally or topically to the animals of respective groups until
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The parameters studied are percentage wound contraction,
hydroxyproline content and epithelialisation time.
17. Drug Administration
A route of administration (ROA) in pharmacology and
toxicology is the path by which a drug, ﬂuid, poison, or other
substance is brought into contact with the body. The goal
is to deliver the drug to the target organ or tissue, so it can
exert its therapeutic eﬀect. The ROA that is chosen may have
ap r o f o u n de ﬀect upon the speed and eﬃciency with which
the drug acts. Treatment of wound includes administration
of drugs either locally (topical) or systemically (oral or
parenteral).
17.1. Topical Administration. Application of HFT to the
w o u n da r e ac a nb ed o n eo n c e ,t w i c e ,o rt h r e et i m e s( a tn-
hour intervals) a day at the group-dependent time intervals
after cleaning with sterile surgical cotton wool in the
experimental group animals (EGA) for a period of n days,
respectively.TheHFTisappliedatadoseof100mg/kg/dayto
500mg/kg/daywithagauzesponge lastedfor10min.Topre-
vent the possible thermic eﬀect of the application, the tem-
peratureofHFTisk eptappro ximately37 ◦C.Thewoundarea
is then covered with a fresh sterile bandage which is secured
by adhesive tape. The commercial Solcoserly jelly or Intrasite
gel or any standard drug ointment/cream, containing 0.2%
to 1% drug (povidone, gentamicin, mupirocin, sulfathiazole,
carboxymethyl cellulose, silver sulphadiazine, chlorhexidine
gluconate, povidone-iodine, and nitrofurazone) in the same
quantity can be applied daily to wounds of reference group
animals (RGA), respectively [53].
Control group animals (CGA) are administered with
the simple ointment base I.P. or B.P. in the same quantity
as a placebo control from zero to the day of complete
healing/epithelialization or the postoperative day, whichever
is earlier. No treatment serves as a negative group. In case,
if the herbal extract is directly used, then it is diluted with
isopropyl lauroyl sarcosinate. After the operation, 10mL
of the vehicle (0.2% or 2%) is soaked into ﬁlter paper
discs and placed on the wound. The ﬁlter paper is covered
with tape and the tape is covered with ﬁlm dressing. The
sample is reapplied and the wound covered again with ﬁlm
dressing at one-week intervals. Since modern medicine uses
antibacterial agents for treatment of wound, the herbal drug
aloe vera (10%) in carbopol can be used as standard [54].
17.2. Oral Administration. HFO is given to the EGA at a
dose of 100mg/kg/day to 500mg/kg/day for n days in case
of incision and dead space wound starting from the day of
wound creation. In case of excision wound model and burn
wound model, the treatment is continued until the day of
scabfalling.TheCGAreceivedplaindrinkingwateronly.The
CGA can also be given normal physiological saline or only
Tween-80 (0.5%–1%) [37, 47].
18. Evaluationof Wound Healing
Wound contraction, which contributes to wound closure,
is expressed as a reduction in percentage of the original
wound size is studied starting from the day of operation
until the day of complete epithelialization and evaluated to
calculate the degree of wound healing. Wound tissues are
analyzed for hydroxyproline content; the collagen composed
of amino acid (hydroxyproline) is the major component
of extracellular tissue, which gives strength and support.
Breakdown of collagen liberates free hydroxyproline and its
peptides. Measurement of hydroxyproline, hence, can be
usedasabiochemicalmarkerfortissuecollagenandanindex
for collagen turnover. The biochemical marker, hexosamine,
a component of the ground substance for the synthesis of
the extracellular matrix is evaluated in granulation tissues
of excision wounds in order to monitor the wound healing
process. Since the level of hexosamine is increased between
7th–12th post wounding day and then decreases slowly; the
granulation tissue is obtained from wound area on 11th post
wounding day [55, 56].
One of the most crucial phases in dermal wound healing
is the progressive increase in biomechanical strength of the
tissue; the mechanical properties of the skin are mainly
attributed to the function of the dermis in relation to the
structure of collagen and elastic ﬁbre networks. Breaking
strength of the healed wound is measured as the minimum
force required to break the incision apart. Skin breaking
strength gives an indication of the tensile strength of
wound tissues and represents the degree of wound healing.
Tensile strength has commonly been associated with the
organization,content,andphysicalpropertiesofthecollagen
ﬁbril network. Tensile strength is the resistance to breaking
under tension; it indicates how much, the repaired tissue
resists breaking under tension and may indicate in part the
quality of the repaired tissue [10]. The sutures were removed
on the 7th–9th post wounding day, and the tensile strength
wasmeasuredonthe8th–10thday.Themeantensilestrength
onthetwoparavertebralincisionsonbothsidesoftheanimal
is taken as the measures of the tensile strength of the wound
for an individual animal [57].
18.1. Percentage Wound Contraction. The progressive reduc-
tion in the wound area is monitored planimetrically by
tracing the raw wound boundaries initially on a sterilized
transparency paper sheet in mm2 without causing any
damage to the wound area, and then, the wound area
recorded is measured using a graph paper on every 2–4d
interval. The period of epithelialization is expressed as the
number ofdaysrequiredforfallingoftheeschar(dead-tissue
remnants) without any residual raw wound is considered as
the end point of complete epithelialisation [58]. Percentage
wound contraction is calculated as:
Percentage wound contraction on
Nth day − 100 =
wound area on Nth day
wound area on 1st day
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18.2. Collagen Estimation. On the 11th post wounding day,
the animals from each group are euthanized and the wound
tissue is excised, weighed, and dried in an oven at 60◦C–
70◦C for 12–18h, and the dry weight is noted. The tissues
are hydrolyzed in 6NHCl for 24h at 110◦C in sealed glass
tubes. The hydrolysate is neutralized to pH 7.0. The sample
(200μL) is mixed with 1mL of 0.01MCuSO4 followed by
the addition of 1mL of 2.5NNaOH and then 1mL of 6%
H2O2. The solution is mixed and shaken occasionally for
5min. All the tubes are incubated at 80◦Cf o r5 m i nw i t h
frequentvigorousshaking.Uponcooling,4mLof3NH2SO4
is added with agitation. Finally, 2mL of 5% para-dimethyl-
aminobenzaldehyde is added to develop a pink colour.
The samples are incubated at 70◦C for 16min, cooled by
placing the tubes in water at 20◦C, and the absorbance is
measured at 540nm using a colorimeter/spectrophotometer.
The amount of hydroxyproline in the samples is calculated
using a standard curve prepared with pure L-hydroxyproline
at the same time [51]. The concentration of the sample is
calculated as:
Concentration of the sample
=
OD of the sample
OD of Standard
×concentration of standard.
(3)
18.3. Hexosamine Estimation. The granulation tissue is
obtained from wound area on 11th post wounding day is
dried in an oven at 60◦C and hydrolyzed with 2NHCl
at 100◦C for 2h. The hydrolyzed solution is ﬁltered and
pH of the ﬁltrate is adjusted to 6-7. This acid hydrolysate
solution is subjected to deamination and nondeamination
of hexosamine to determine the amount of hexosamine. For
deamination, 0.5mL of a 5% solution of sodium nitrite
and 0.5mL of a 33% solution of acetic acid is added to
0.5mL of acid hydrolysate solution. The tubes are shaken
and left for 10min for complete deamination. The excess
nitrousacidisremovedbyadding0.5mLofa12.5%solution
of ammonium sulfamate and by shaking the mixture for
30min. For indole reaction, 2mL of 5% HCl and 0.2mL
of a 1% solution of indole in alcohol is added to 2mL of
the deaminated hexosamines. The tubes are immersed for
5min in a boiling water bath. An intense orange colour
and a slight turbidity is seen. To remove turbidity, 2mL of
alcohol is added, and tubes are shaken. For nondeamination
of hexosamine, 1.5mL of a mixture of equal volumes
of solutions of 5% sodium nitrite, 33% acetic acid and
12.5% ammonium sulfamate are added to 0.5mL of acid
hydrolysate solution. This serves as the control without
deamination. The indole reaction is carried out on this
mixtureasdescribed above.Theabsorbancesofthesolutions
are determined spectrophotometrically at 492 and 520nm.
The absorbance value for the nondeaminated solutions is
subtracted from the corresponding absorbance values for the
deaminatedunknownandstandardsolutionsofglucosamine
hydrochlorides. The increase in the diﬀerence in absorbance
afterthedeaminationprocedureisconsideredasthemeasure
of the amount of hexosamine. The hexosamine value in μgi s
computed from the standard curve [56].
18.4. Skin Breaking Strength. The anesthetized animal is
secured to the table, and a line is drawn on either side of the
wound 3mm away from the suture line. Two allice forceps
are ﬁrmly applied on to the line facing each other. One of the
forceps is supported ﬁrmly, whereas the other is connected
to a freely suspended light weight metal pan/measuring
graduated container through a string run over to a pulley.
Weight is added to the pan/water is allowed to ﬂow from
the reservoir slowly and continuously into the container. A
gradual increase in weight is transmitted to the wound site
pulling apart the wound edges. As soon as wound gaping
appeared, the addition of weight/water ﬂow is stopped, and
the weights added to pan/volume of water collected in the
container (approximately equal to its weight) is determined
and noted as a measure of breaking strength in grams. Three
readings are recorded for a given incision wound, and the
procedure is repeated on the contralateral wound. The mean
reading for the group is taken as an individual value of
breaking strength. The mean value gives the skin breaking
strength for a given group [11, 16].
In another approach, the animal is anaesthetized, and
healing tissue along with normal skin at the two ends is
excised. Strips of 8mm width and 20mm length are cut out
from the excised tissue, which is loaded between the upper
and lower holder of the tensile testing machine in such a
way that the eﬀective load bearing size is 8 × 8mm with
the wound remaining in the centre [46]. The total breaking
load is measured in Newtons (N), and the tensile strength is
calculated as mass in kg by the following equation: Tensile
strength=Total breaking load/Cross-sectional area.
18.5. Granuloma Studies. The day of the wound creation
is considered as day zero. Granulation tissue forms on the
dead space wound surrounding the implanted pellets/piths
is harvested by careful dissection on the 10th post wounding
dayunderlightetheranaesthesia.Afternotingthewetweight
of the piece of granuloma excised, it is dried in an oven at
60◦C for 12–24h to obtain a constant dry weight expressed
asmg/100gbodyweight.Thegranulomatissuesaretrimmed
to obtain the rectangular strip measuring about 15mm in
length and 8mm width to determine its breaking/tensile
strength by continuous water ﬂow technique. The dry
granulation tissue is used for the estimation of hexuronic
acid, hexosamines, hydroxyproline content, which can be
assayed calorimetrically/spectrophotometrically, and a piece
of wet granuloma is preserved in 10% formaldehyde for
histological studies to evaluate the eﬀect of the herbal extract
on collagen formation [2, 14]. Granulation tissue is collected
in phosphate-buﬀered saline (maintained at −64◦C) for the
estimation of antioxidant enzymes like superoxide dismutase
(SOD), catalase, reduced glutathione (GSH), and tissues
lipid peroxidation [10].
19.Histopathological Studies
The regenerated tissue samples are evaluated for the follow-
ing histological criteria: the extent of re-epithelialization or
ulcus in epidermis, the maturation and organization of theEvidence-Based Complementary and Alternative Medicine 11
epidermal squamous cells, the thickness of the granular cell
layer, the degree of the tissue formation in wounds, and
their comparison with the normal tissue part. In addition,
angiogenesis, congestion, edema, epithelialization, ﬁbrob-
lasts proliferation, intensity and extent of inﬂammation (cell
inﬁltration), mononuclear and/or polymorphonuclear cells,
necrosis, ulceration, neovascularization, and the pattern of
collagen depositions in the dermis are qualitatively evaluated
to score the epidermal or dermal remodeling. In case of burn
wounds, all the histological criteria are evaluated after 25d
and the last day of the treatment period. For this purpose,
tissue samples were taken with a small excision containing
part of the wound area.
The cross-sectional full-thickness specimen of granula-
tion tissues is obtained on 10th-11thd or at the end of
the experiment from the complete healed wounds of all the
four groups of surviving animals is subjected to histological
examination. The granulation tissues are separately ﬁxed
in 10% neutral phosphate buﬀered formalin solution for
48h. The formalin-ﬁxed tissues are dehydrated through
graded alcohol series, cleared in xylene and embedded in
paraﬃn wax. Serial sections of 4–7mm thickness from
the paraﬃn embedded regenerated tissue are cut using a
microtome. The sections are processed in alcohol-xylene
series and stained with hematoxylin and eosin (HE) or
Mallory Azan or toluidine blue (TB) stain and observed
for the histological changes under a light microscope and
photomicrographs are taken. The number of capillaries is
counted in HE stained sections, the collagen area in the
granulation tissue is measured in Azan-stained sections and
metachromaticstainedmastcellsareexaminedinTBstained
sections. The number of capillaries is counted in three parts
of the granulation tissue (upper, center, and lower). The
area of collagen synthesis is derived from the area stained
blue by the Azan stain. For better appreciation of collagen
deposition Van Geison’s (VG) stain is used, which stains the
collagen ﬁbres pink, and Masson’s trichrome (MT) stain is
used that stains the collagen ﬁbres green are performed on
paraﬃn sections, followed by photomicrography. Sections
are analyzed and scored as mild (+), moderate (++) and
severe (+++) for epidermal or dermal remodeling. The
severity of inﬂammation in healed areas is evaluated by
counting the mean number of inﬂammatory cells inﬁltration
per high ﬁeld (PHF) (×400 magniﬁcation) of three samples
of each group [59–61].
20. Effects of In vivo Studies
In the excision and burn wound model studies the herbal
extract showed increased rate of wound contraction and
decrease in period of epithelization in experimental group
animals (EGA) as compared to control (placebo, negative)
group animals (CGA). For example, the herbal extracts of
Acacia nilotica [40], Aspilia africana [20], Emblica oﬃcinalis
[61], Memecylon umbellatum [53], and Rubia cordifolia [41]
were screened using excision wound model whereas the
herbal extracts of Achillea millefolium [50], Carica papaya
[51], Centella asiatica [49], Cocos nucifera [52], and Crocus
sativus [60]w e r et e s t e de m p l o y i n gb u r nw o u n dm o d e lf o r
the analysis of their wound healing potential.
In the incision wound model studies, the herbal extract
showed signiﬁcant increase in tensile strength in EGA as
compared to CGA. For example, the herbal extracts of
Allamanda cathartica [55], Alternanthera brasiliana [25],
Anogeissuslatifolia[57],Caralliabrachiata[45],andCynodon
dactylon [16] were analysed using incision wound model
for the determination of their wound healing potential. In
the dead space wound model studies, the herbal extract
showed signiﬁcant increase in collagen deposition showing
fewer macrophages and ﬁbroblasts and increase in the dry
weight of granulation tissue in EGA as compared to CGA
with more aggregation of macrophages with few collagen
ﬁbres. For example the herbal extracts of Allium cepa [44],
Areca catechu [48], Berberis lyceum [47], Carapa guainensis
[11], and Carica papaya [51] were screened employing dead
space wound model for the analysis of their wound healing
potential.
Microscopic histopathological examination of the sec-
tions prepared from the wounds of EGA, CGA, and RGA
exhibited the following characteristics. The regenerated
tissue section of CGA showed densely inﬂamed connective
tissue with chronic inﬂammatory cells between the collagen
ﬁbers; this shows incomplete wound healing. The tissue
of RGA is composed of dense collagen ﬁbers, ﬁbroblasts
with round to oval nuclei and blood vessels, many thin
walled blood vessels are present, whereas the regenerated
tissue section of herbal extract-treated EGA showed ﬁbrous
connective tissue with scattered inﬂammatory cells and
ﬁbroblasts. There was a progressive collagenation with few
thin-walledbloodvesselswithsmalllumina,epithelialisation
of tissues was also observed. The EGA showed dense ﬁbrous
tissue with thick collagen bundles, ﬁbroblasts, and scattered
inﬂammatory cells. The appearance was almost identical to
that of normal tissues. The results showed that the wound
healing was faster in the EGA as compared to CGA and RGA
[16, 58].
21. Discussion
There is an increasing interest in ﬁnding herbal extracts with
wound healing eﬃcacy although the use of such extracts
for treating cuts and wounds is a common practice in
traditional medicine. Wound infection resulting from the
impaired immunity and exposure or poor hygiene is one of
the most commonly encountered and clinically important
impediments to wound healing. The injured skin remains
vulnerable to invasive microbial infections of all kinds subse-
quent development of wound sepsis until complete epithelial
repairs has occurred [21]. Injury becomes infected, because
the wound area is an ideal medium for the multiplication
of the infecting organism. Topical antimicrobial therapy
is one of the most important methods of wound care
[12]. The herbal extracts and fractions eﬀectively arrested
bleeding from fresh wounds, inhibited microbial growth
and accelerated wound healing [20]. The enhanced wound
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to free radical-scavenging action and the antimicrobial
property of the phytoconstituents present in the extract, and
the quicker process of wound healing could be a function
of either the individual or the synergistic eﬀects of bioactive
molecules. These active constituents promote the process
of wound healing by increasing the viability of collagen
ﬁbrils, by increasing the strength of collagen ﬁbers either by
increasingthecirculationorbypreventingthecelldamageor
by promoting the DNA synthesis [62].
Pronounced eﬀects on ﬁbroblast motility and cellular
proliferation due to the mitogenic activity of herbal extract
correlate with its wound healing eﬀect being predominantly
dermal. During wound repair, ﬁbroblasts migrate from the
woundedgestothewoundsite,proliferate,andsubsequently
produce collagen, the main component in the extracellular
matrix. Stimulation of ﬁbroblasts is one mechanism by
which herbal extracts might enhance the wound repair
process. Although keratinocytes also need to migrate from
the wound edge to provide a provisional matrix for the
ﬁbroblaststomigrateon,thismightbeacceleratedsecondary
to a mature dermal matrix. These latter eﬀects on ﬁbroblasts
probably are the result of phytoconstituents of herbal extract
that may have a growth factor-like activity or have the ability
to stimulate the early expression of growth factors [30].
Keratinocyte migration is an event in the wound healing
process which may sometimes be arrested even when there
is a development of good granulation tissue. Migration is
inﬂuencedbythenatureofsurroundingextramatrixandthe
protein composition of the wound environment [29].
It is known that herbal extracts may be contaminated
by endotoxins, depending on the conditions and method of
preparation. These are lipopolysaccharides (LPS) associated
with the cell wall of gram-negative bacteria and have various
biological eﬀects. Therefore, the herbal extracts must be
assayedforendotoxinandalsoinvestigatetheeﬀectofanLPS
from E. coli on the growth of skin cells in vitro [29]. Due to
increasing evidence that bacteria in wounds with potential
chronicity live within bioﬁlm communities, protecting them
from host defences, the study of bioﬁlm has become an
area of intense scientiﬁc investigation in wound healing and
bacterialresistance, both of whichare relevant to the diabetic
state [38].
The increasing use of traditional medicines and therapies
demands more scientiﬁcally sound evidence for the prin-
ciples behind therapies and for eﬀectiveness of medicines.
Recent advancements in the analytical and biological sci-
ences, along with innovations in genomics and proteomics
can play an important role in the validation of these
therapies. Modern therapy requires the targeting of drugs
directly to the site of interest and to accomplish that goal in
systemictreatment.Geneandstem-celltherapyareemerging
as a new and promising approach for enhancing treatment of
wound healing [63].
Embryonic and adult stem cells have a prolonged self-
renewal capacity with the ability to diﬀerentiate into various
tissue types. Stem cells are attracted to areas of wound
healing and have the ability to multiply and then divide
into the cells needed to repair the damage. Stem cells have
revolutionary clinical potential, because they can be used
as a therapeutic intervention for treating many injuries,
including brain repair and regeneration, in many instances.
A variety of sources, such as bone marrow, peripheral blood,
umbilical cord blood, adipose tissue, skin and hair follicles,
have been utilized to isolate stem cells to accelerate the heal-
ing response of acute and chronic wounds [64]. Stem cells
harboured within adult bone marrow contribute to wound
angiogenesis. These cells, known as endothelial progenitor
cells (EPCs), can also be isolated in small numbers from the
peripheral circulation of normal healthy adults. Following
injury, EPCs are mobilized into the circulation, and they
home sites of neovascularization, where they diﬀerentiate
into adult endothelial cells. Placental growth factor (PlGF),
a member of the vascular endothelial growth factor (VEGF)
family, and its receptor ﬂt-1 (VEGF-R1) have been identiﬁed
as regulators for EPC recruitment in angiogenesis. Stem
cells could also possibly be an important factor in delaying,
slowing, and in some instances, halting, deterioration, even
reversing the course of a sudden acute injury or acute onset
crisis situation. Enhanced understanding of these cells may
help develop novel therapies for diﬃcult cutaneous condi-
tions such as nonhealing chronic wounds and hypertrophic
scarring as well as engineering cutaneous substitutes [65].
In order to accelerate wound closure, genes encoding
for growth factors or cytokines showed the greatest poten-
tial. Modern functional genomics approaches may facilitate
a better understanding of the molecular events involved
in tissue morphogenesis and allow the identiﬁcation of
molecular signatures and pathways. The tools of genomics
and proteomics will be used to proﬁle individual wounds
in order to tailor therapy for patients. Gene therapy or
cell-based therapy delivering angiogenic growth factors and
recombinant protein therapy may oﬀer advantages over
other wound healing therapies [66]. Novel growth factor
delivery systems are now under investigation, such as
angiogenic gene sutures, autologous stem-cell transplanta-
tion, genetically modiﬁed tissue engineered constructs, and
growth factor impregnated dressings or sprays. As wound
research and technology development continue, these eﬀorts
will undoubtedly reveal new opportunities for accelerating
wound healing. The functional genomics and proteomics
and knowledge of cell signalling networks may contribute
substantiallytodevelopingamolecularevidence-basedCAM
and pave the way to novel approaches in tissue engineering
and regeneration [67].
Novel delivery vehicles, generated through nanotechnol-
ogy is raising the novel and stirring prospect for controlled
andsustaineddrugdeliveryacrosstheimpenetrableskinbar-
rier is a magniﬁcent clinical application of nanotechnology
for wound management. Particles of 500nm size and smaller
exhibit a host of unique properties that are superior to their
bulk material counterparts. Small size is a necessary feature,
but other properties are needed for nanomaterials to achieve
eﬃcacy as a topical delivery vehicle [68]. Additionally,
these products should be able to adjust to relevant physi-
ologic variations as part of their design and targeting. The
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severalnanometersindiametergreatlyincreasestheavailable
surface area compared to bulk silver and dramatically
changes its properties. Silver nanoparticles have been shown
to have many beneﬁcial properties for wound management,
including antibacterial activity, antifungal activity, and even
anti-inﬂammatory properties [69].
Nanoﬁbers also exhibit properties that may be beneﬁcial
in burn care, including a large surface area to volume ratio,
high porosity, improved cell adherence, and controlled in
vivo degradation rates. Thus, the nanoﬁber scaﬀolds have
immediate applications as dressings for burn wounds and
signiﬁcant potential in drug delivery [70]. The delivery of
nitric oxide (NO) radicals using nanotechnology is possible
by trapping NO radicals stably within a dry matrix, from
where they can be released over an extended period and
at a relatively ﬁxed concentration. The potential of NO-
nanoparticlesinwoundmanagementhasbeendemonstrated
in numerous animal studies, suggesting that this technology
m a yu l t i m a t e l yo ﬀer an eﬀective alternative in the treatment
of wound infections [71]. Recombinant human epidermal
growth factor (rhEGF) nanoparticles is prepared by utilizing
a modiﬁed double-emulsion method with poly(lactic-co-
glycolic acid), as the carrier and the controlled release
of rhEGF nanoparticles enhances its eﬀects in stimulating
proliferationofthemouseﬁbroblastsandshortenthewound
healing time in diabetic rats with full-thickness wounds,
divided into four groups according to treatments: rhEGF
nanoparticles, rhEGF stock solution, empty nanoparticles,
and phosphate-buﬀered saline [72].
The complex cellular and molecular signalling and reg-
ulatory processes underlying development and homeostasis
can only be understood comprehensively by analysis in the
intact living organism. Molecular interactions are frequently
transient and context dependent, necessitating in vivo anal-
ysis to generate relevant insights into the molecular mecha-
nisms. Biomedical research and drug development have thus
an increasing need to analyse and monitor these dynamic
processes in cellular physiology, development, and disease
in the living organism using bioimaging technologies [73].
Bioimaging enables the discovery and tracing of biomarkers
of drug response is an increasingly important ﬁeld of
advanced research. Biomarkers are biological indicators of
disease or healing eﬀects that can be measured by in vivo
biomedical imaging and molecular imaging in particular, as
well as other in vitro or laboratory methods. Recent work
has shown that biomedical imaging can provide an early
indication of drug response by use of X-ray, CT, or PET-
CT. Bioimaging will help scientists to probe the complex
relationships between genes, proteins, cellular components,
and physiological systems. Nano-bio-imaging is the entirety
of various kinds of imaging technology supported by
nanotechnology, and it enables further progress of research
in nanomedicine and nanotechnology. This new form of
bioimaging will play a powerful role in the emerging ﬁeld of
systems biology.
These technologies allow precise tracking of metabolites
which can, in turn, be used as biomarkers for disease
identiﬁcation, progress, and treatment response. Discovery
and development of disease biomarkers in animal models
can then be transferred to use in clinical settings. In the
realm of nanotechnology, drug delivery to speciﬁc targets,
controlled drug release and monitoring oﬀers opportunities
for molecular imaging technologies to make signiﬁcant
impacts on both pharmacology and early clinical trials
[74]. The in vitro assays are relatively inexpensive and give
more rapid results for initial screening of large numbers of
agents. Deﬁnitive conclusions cannot be based on in vitro
assays alone. However, an ability to inhibit endothelial cell
proliferation, migration and tubule formation in vitro may
not predict in vivo response. In vivo assays provide a more
complete physiologic assessment of angiogenesis, but they
are more time consuming and expensive.
Wound healing generally requires support at three levels.
First, improving general resistance and support mechanisms
that could be obtained from rejuvenative, adaptogenic,
palliative, antioxidant, cleansing, detoxifying, buﬀering, and
lubricous activities. Second, stimulating the repair and
regenerative mechanisms to prolong cell life, cell migration
and cell binding, remove skin blemishes, and improve tensile
strength or elasticity of the skin, improve moisture-holding
capacity of skin. Third, therapeutic and nutritional activities
including anti-inﬂammatory, antiseptic, and antimicrobial,
protein and collagen synthesis and increased stability of
biomembranes. Antioxidants can interfere with the oxida-
tion process by reacting with free radicals, chelating catalytic
metals and by acting as oxygen scavengers. Free radicals and
other reactive oxygen species (ROSs) are considered to be
important causative factors in delaying the healing process
[75].
At high concentrations, ROSs can induce severe tissue
damage and even lead to neoplastic transformation, which
further impede the healing process by causing damage to
cellular membranes, DNA, proteins, and lipids as well.
Hence, if an herbal extract having antioxidant potentials
and an additional antimicrobial activity, it could be a
good therapeutic agent for accelerating the wound healing
process [76]. Oxidative stress also plays an important role
in impaired wound healing. This oxidative stress may cause
damage to the growing tissue at the repair site. In case of
burn wound, microcirculation is generally compromised,
resulting in a restriction or cessation of blood ﬂow, which
in turn causes ischemia and subsequently a reperfusion,
and thus generates oxidative stress. Intervention that could
restore blood ﬂow or scavenging the free radicals should, in
principle, reduce the damage due to oxidative stress [49].
Thus, the antioxidants present in the herbal extract could be
expected to promote epithelization by controlling oxidative
stress. Botanicals with antioxidant or free radical-scavenging
activity thus can play a signiﬁcant role in healing of wounds
[39].
Pharmaceutically as well as biologically, the herbal
extracts promote fast wound healing than control and
non medicated group in diﬀerent in vivo studies. The
process of wound healing is promoted by several herbal
extracts,whicharecomposedofactiveagentsliketriterpenes,
alkaloids, ﬂavonoids, tannins, saponins, anthraquinones,
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metabolites/compounds isolated from plants have been
demonstrated in animal models as active principles respon-
sible for facilitating healing of wounds. Some of the most
important ones include oleanolic acid, polysaccharides,
gentiopicroside, sweroside, swertiamarin, shikonin deriva-
tives (deoxyshikonin, acetyl shikonin, 3-hydroxy-isovaleryl
shikonin, and 5,8-Odimethyl acetyl shikonin), asiatico-
side, asiatic acid, madecassic, quercetin, isorhamnetin,
kaempferol, curcumin, sesamol (3,4 methylenedioxyphe-
nol), coluteol, colutequinone B, hyperforin, catechins, and
isoﬂavonoids that could potentially be new therapeutic
agents to treat wounds. These agents usually inﬂuence one
or more phases of the healing process [41].
Tannins act as free radical scavengers, triterpenoids, and
ﬂavonoids promote wound healing due to their astringent
and antimicrobial property, and saponins due to their
antioxidant and antimicrobial activity, which appear to be
responsible for wound contraction and elevated rate of
epithelialization. Flavonoids also possess potent antioxidant
and free radical-scavenging eﬀect, enhancing the level of
antioxidant enzymes in granuloma tissue [44]. Sterols and
polyphenols are also responsible for wound healing due
to free radical-scavenging and antioxidant activity, which
are known to reduce lipid peroxidation, thereby reduce
cell necrosis and improving vascularity [40]. Several types
of injuries like burn, wounds, and skin ulcers usually
generate superoxides and lipid peroxidation through the
activation of neutrophils. Hence, any drug that inhibits
lipid peroxidation is believed to increase the viability of
collagen ﬁbrils by increasing the strength of collagen ﬁbres,
increasing the circulation, preventing the cell damage, and
by promoting the DNA synthesis. Better collagenation seen
u n d e rt h ei n ﬂ u e n c eo fs o m eh e r b a le x t r a c t sm a yb eb e c a u s e
of improved antioxidant status. Thus, an intervention into
any one of these phases by drugs could eventually lead to
either promotion or depression of the collagenation phase of
healing [77].
The need for in vivo studies arose from the fact that the
wound healing process involves granulation, collagenation,
collagen maturation and scar maturation are some of many
phases and very few drugs are available that can act directly
on all the phases. Whereas the use of a single model is
inadequateandthereisnoreferencestandard,whichcancol-
lectivelyrepresentthevariouscomponentsofwoundhealing,
as drugs which inﬂuence one phase may not necessarily
inﬂuence another. Hence, diﬀerent models are necessary
to assess the eﬀect of herbal extract on various phases of
wound healing, which run concurrently, but independent of
each other [37]. Percentage utilization of diﬀerent wound
models for in vivo studies is presented in Figure 4. The data
was calculated from the published original research articles
compiled from various sources during the composition of
this paper.
Topicallyadministereddrugsareeﬀectiveinfasterwound
contraction due to the larger availability at the wound site.
An ointment with water-soluble base is of ﬁrst choice due
to their ease of preparation and eases of cleaning after
application. The medicaments are dispersed in the base,
and later they get divided after the drug penetration into
Burn wound
model
5%
Incision wound
model
28%  Dead space
model
18%
Excision wound
model
49% 
Figure 4: Percentage utilization of diﬀerent wound models for in
vivo studies, calculated from the published research articles.
the living cells of skin [78]. The results of various studies
performed so far are signiﬁcant for diﬀerent parameters in
wound healing activity when compared with the control
group and showed that the usage of herbal extracts signiﬁ-
cantly accelerated wound healing. Increased hydroxyproline
content is a reﬂection of increased collagen content, which
implies an eﬀect on the early granulation or proliferation
phase in treated wounds. Increased hexosamine content
reﬂects the stabilization of collagen molecules by enhancing
electrostatic and ionic interactions with it, which in turn
reﬂects remodeling of the new extracellular matrix produced
[30].
Essential trace elements especially zinc and vitamin C,
vitamin E also inﬂuences the process of wound repair. Zinc
is one of the essential trace elements and serves as a cofac-
tor in various enzyme systems, including zinc-dependent
matrix metalloproteinases, which augment autodebride-
ment and keratinocyte migration during wound repair
processes. It also provides resistance to epithelial apoptosis
via cytoprotection, probably through antioxidant activity of
the cysteine-rich metallothioneins, against reactive oxygen
species and bacterial toxins. Deﬁciency of zinc in the body,
either hereditary or dietary, can lead to delayed wound
healing. Zinc content of the plant extracts used for wound
healing purposes might have a great contribution in the
healing process. Topical administration of zinc is superior
to oral administration because of its eﬀect in reducing super
infections and necrosis via enhanced local defence systems
and the sustained release of zinc ions, which stimulates re-
epithelialization of wounds. Vitamin C also acts as cofactors
or coenzymes in a number of metabolic functions involved
in wound healing. Hence, zinc and vitamin C levels of the
herbal extracts can be determined [79].
When attempting to use or develop a model for wound
healing studies, the beneﬁts and disadvantages must be
considered carefully, since a model attempts to imitate
some other situation. Generally, animal models approximateEvidence-Based Complementary and Alternative Medicine 15
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4%
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Figure 5: Percentage utilization of diﬀerent animals for in vivo
studies, calculated from the published research articles.
human wound healing studies better than in vitro assays.
However,thechoiceofanimalcanbediﬃcult,sinceitsability
to represent human wound healing must be coupled with
its practicality. Percentage utilization of diﬀerent animals
for in vivo studies is presented in Figure 5, the data of
which was calculated from the published original research
articles. Although the rat, mouse, rabbit, and guinea pigs
wound models exist, swine skin is the most similar to
humans and has been shown to be an excellent tool to
evaluatewoundhealingtherapies.Porcineskinisstructurally
similar to human skin with similar epidermal thickness and
dermal-epidermal thickness ratios. The hairless mouse can
be selected as a wound model for epidermal injury, because
itoﬀersseveraladvantages.First,theepidermisdoesnothave
a fur coat, which interferes with the separation of epidermis
from dermis; second, the size and economy of a hairless
mouse make it an ideal model to evaluate the eﬀects of
pharmacological agents on the wound healing process [27].
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